Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$272.73 USD
+1.73 (0.64%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $272.72 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.50 | -41.06% |
Earnings Summary
For their last quarter, Alnylam Pharmaceuticals (ALNY) reported earnings of $0.56 per share, beating the Zacks Consensus Estimate of $-0.74 per share. This reflects a positive earnings surprise of 175.68%. Look out for ALNY's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.50 per share, reflecting a year-over-year decrease of 143.48%.
Earnings History
Price & Consensus
Zacks News for ALNY
ALNY Down Despite Positive Data From Heart Disease Drug Study
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services